Acetazolamide teratology and its association with carbonic anhydrase inhibition in the mouse.
Acetazolamide, an inhibitor of the enzyme carbonic anhydrase (E.C. 4.2.1.1.), causes a unique congenital anomaly characterized by postaxial reduction of the distal portion of the right forelimb. To gain an understanding of the mechanism of teratogenesis, the activity of carbonic anhydrase in sensitive and resistant mouse strains, and its inhibition by acetazolamide, were examined. Differences in teratologic sensitivity were found not to be attributable to differences in maternal or embryonic drug levels. Enzyme inhibition at acetazolamide concentrations ranging between 10(-11) and 10(-5) M did not differ between the mouse strains when adult erythrocytes or day 12 embryos were assayed. However, in day 10 embryos, the period of maximum teratologic susceptibility, a small strain difference was found which suggested that the form of carbonic anhydrase in the susceptible CBA/J strain at this time is somewhat more sensitive to inhibition by acetazolamide than the form found in the resistant SWV strain. The results suggest further that more than one isozyme of carbonic anhydrase may be present in all three samples.
D000086:Acetazolamide / Q000633:toxicity*; D000818:Animals; D002257:Carbonic Anhydrase Inhibitors / Q000633:toxicity*; D005260:Female; D007700:Kinetics; D051379:Mice; D008815:Mice, Inbred Strains; D011247:Pregnancy; D013723:Teratogens; D013997:Time Factors
D002257:Carbonic Anhydrase Inhibitors; D013723:Teratogens; D000086:Acetazolamide